sellNotable cluster of 3
Renee Lentini sold $3.4M of IMGN
VP & PRIN ACCTG OFFICER at ImmunoGen, Inc.. 219,545 shares at an average of $15.29, traded Nov 6, 2023, filed Nov 8, 2023.
Warning score
60Value
$3.4M
219,545 shares
Holdings after
0
-100% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +25Trade size$3.4M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-23-014916, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 6, 2023 | MOption exercise Common Stock | +9,000 | $10.79 | $97k | 108,017 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Common Stock | +2,619 | $2.68 | $7,019 | 110,636 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Common Stock | +23,000 | $10.65 | $245k | 133,636 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Common Stock | +14,373 | $5.25 | $75k | 148,009 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Common Stock | +4,024 | $6.98 | $28k | 152,033 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Common Stock | +55,550 | $7.69 | $427k | 207,583 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Common Stock | +11,962 | $5.32 | $64k | 219,545 | Nov 8, 2023 |
| Nov 6, 2023 | SOpen-market sale Common Stock | -219,545 | $15.29 | $3.4M | 0 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Stock Option (right to buy)derivative | -9,000 | $0.00 | $0 | 0 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Stock Option (right to buy)derivative | -2,619 | $0.00 | $0 | 0 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Stock Option (right to buy)derivative | -23,000 | $0.00 | $0 | 0 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Stock Option (right to buy)derivative | -14,373 | $0.00 | $0 | 0 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Stock Option (right to buy)derivative | -4,024 | $0.00 | $0 | 12,625 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Stock Option (right to buy)derivative | -55,550 | $0.00 | $0 | 25,250 | Nov 8, 2023 |
| Nov 6, 2023 | MOption exercise Stock Option (right to buy)derivative | -11,962 | $0.00 | $0 | 53,831 | Nov 8, 2023 |
Related signals
Other insiders at ImmunoGen, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 6Weak | ImmunoGen, Inc. | Stacy Ann Coen SVP & CHIEF BUSINESS OFFICER | $134k 4,583 shares | -6% | |
| 24Weak | ImmunoGen, Inc. | Mark J Enyedy CHIEF EXECUTIVE OFFICER | $589k 20,107 shares | -3% | |
| 8Weak | ImmunoGen, Inc. | Renee Lentini VP & PRIN ACCTG OFFICER | $77k 2,631 shares | -15% | |
| 20Weak | ImmunoGen, Inc. | Theresa Wingrove SVP OF REGULATORY AFFAIRS | $352k 12,027 shares | -36% | |
| 25Weak | ImmunoGen, Inc. | Theresa Wingrove SVP OF REGULATORY AFFAIRS | $5.6M 187,667 shares | -98% | |
| 10Weak | ImmunoGen, Inc. | Renee Lentini VP & PRIN ACCTG OFFICER | $195k 6,548 shares | -44% | |
| 33Weak | ImmunoGen, Inc. | Theresa Wingrove SVP OF REGULATORY AFFAIRS | $3.5M 117,445 shares | -98% | |
| 25Weak | ImmunoGen, Inc. | Stacy Ann Coen SVP & CHIEF BUSINESS OFFICER | $112k 3,826 shares | -10% | |
| 34Weak | ImmunoGen, Inc. | Kristine Peterson director | $578k 20,000 shares | -100% | |
| 40Moderate | ImmunoGen, Inc. | Theresa Wingrove SVP OF REGULATORY AFFAIRS | $4.9M 171,216 shares | -1783% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.